Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Ligand_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2009
|
| gptkbp:focus |
central nervous system disorders
|
| gptkbp:foundedYear |
1987
|
| gptkbp:headquartersLocation |
gptkb:Branford,_Connecticut,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:NRGN
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:bfsParent |
gptkb:Frank_Charles_Carlucci_III
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
Neurogen
|